Cleared Traditional

K862833 - MODEL 303-47/303-48 ALANINE AMINOTRANSF...

K862833 is the FDA 510(k) clearance for MODEL 303-47/303-48 ALANINE AMINOTRANSF... by Diagnostic Chemicals, Ltd. (Usa). It is a Class 1 Chemistry device (product code CKA) cleared through the Traditional 510(k) pathway after a 25-day FDA review.

K862833 · Diagnostic Chemicals, Ltd. (Usa) · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1986
Decision
25d
Days
Class 1
Risk

K862833 is an FDA 510(k) clearance for the MODEL 303-47/303-48 ALANINE AMINOTRANSFERASE KIT. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Diagnostic Chemicals, Ltd. (Usa) (Charlottestown,Pei,Canada, CA). The FDA issued a Cleared decision on August 19, 1986 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Chemicals, Ltd. (Usa) devices

Submission Details

510(k) Number K862833 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 1986
Decision Date August 19, 1986
Days to Decision 25 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 88d · This submission: 25d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 98
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K862833.
ALT S.C.E. (GPT)
K863053 · J. D. Assoc. · Dec 1986
EMDS(TM) ALANINE AMINOTRANSFERASE (ALT) #67658/95
K863962 · Em Diagnostic Systems, Inc. · Nov 1986
ALT/GPT PROCEDURE
K863253 · Data Medical Associates, Inc. · Sep 1986
TWIN GOT-AST IFCC/GPT-ALT IFCC
K861792 · Boehringer Mannheim Corp. · Jul 1986
ALT (SGPT) REAGENT SET (UV RATE)
K862209 · Sterling Diagnostics, Inc. · Jun 1986
ALT/GPT PROCEDURE
K861658 · Data Medical Associates, Inc. · May 1986